SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-18-042844
Filing Date
2018-11-09
Accepted
2018-11-09 16:01:49
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 657970
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 107814
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 8866
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 8554
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6486
  Complete submission text file 0001140361-18-042844.txt   3760443

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ast-20180930.xml EX-101.INS 515081
7 XBRL TAXONOMY EXTENSION SCHEMA ast-20180930.xsd EX-101.SCH 42015
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ast-20180930_cal.xml EX-101.CAL 51169
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ast-20180930_def.xml EX-101.DEF 191734
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ast-20180930_lab.xml EX-101.LAB 517487
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ast-20180930_pre.xml EX-101.PRE 295736
Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805
Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)

IRS No.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36646 | Film No.: 181173038
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1